about
Antiviral perspectives for chikungunya virusNovel chikungunya vaccine candidate with an IRES-based attenuation and host range alteration mechanismProduction of Chikungunya Virus-Like Particles and Subunit Vaccines in Insect CellsCross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccineProbing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signalingA virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infectionDNA vaccine initiates replication of live attenuated chikungunya virus in vitro and elicits protective immune response in micePrime-boost immunization strategies against Chikungunya virusMultiple immune factors are involved in controlling acute and chronic chikungunya virus infectionDissecting the Role of E2 Protein Domains in Alphavirus PathogenicityAntiviral Hammerhead Ribozymes Are Effective for Developing Transgenic Suppression of Chikungunya Virus in Aedes aegypti MosquitoesChikungunya vaccines in developmentThe Global Virus Network: Challenging chikungunyaReal-time whole-body visualization of Chikungunya Virus infection and host interferon response in zebrafishDevelopment of a highly protective combination monoclonal antibody therapy against Chikungunya virusA nonhuman primate model of chikungunya diseaseChikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies.Development of Vaccines for Chikungunya Fever.Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.Next generation sequencing of DNA-launched Chikungunya vaccine virus.Chikungunya: a potentially emerging epidemic?A DNA vaccine against chikungunya virus is protective in mice and induces neutralizing antibodies in mice and nonhuman primatesA small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in miceChikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose.Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island.Chikungunya virus arthritis in adult wild-type mice.Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein.Novel attenuated Chikungunya vaccine candidates elicit protective immunity in C57BL/6 mice.Effective chikungunya virus-like particle vaccine produced in insect cells.Stability of RNA virus attenuation approachesA complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritisBiodefense Oriented Genomic-Based Pathogen Classification Systems: Challenges and Opportunities.Venezuelan equine encephalitis virus variants lacking transcription inhibitory functions demonstrate highly attenuated phenotype.Transmission potential of two chimeric Chikungunya vaccine candidates in the urban mosquito vectors, Aedes aegypti and Ae. albopictus.Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine designConservation of a packaging signal and the viral genome RNA packaging mechanism in alphavirus evolution.Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line.Chimeric Chikungunya viruses are nonpathogenic in highly sensitive mouse models but efficiently induce a protective immune response.Chikungunya virus: evolution and genetic determinants of emergence.
P2860
Q21284682-3BC0026D-D436-46A6-B887-CB066A16E385Q21559402-66E05257-8330-4C60-BC2C-BB975627E8DBQ24261442-4DC48FBE-8976-48B8-9A11-A5FF2405DE4EQ24276414-2EC95D70-9BA5-4949-88E8-647D1B59809AQ24608725-7CD075F0-03B9-4E5F-9C14-A0F72E5E69D1Q24631774-4F401399-B31F-46ED-903E-AE27CAC4ED22Q24701765-0EDEA6DD-BB1C-4802-B26D-99061F67592FQ24701774-ABB7B2B8-24D3-4923-B9AF-4A9C6EFB692BQ24701792-61124B48-12F5-4F9D-9171-C032019D7421Q26314381-5493DAFC-E17A-4074-B9B0-20851A6C69E2Q26314624-B067CCA1-6997-4C64-9358-BD879334BA56Q26700081-FA71F1CE-1791-483D-8BED-ECCEF528505EQ26700155-BA55C575-F36C-4A38-8628-FA9349F51CEFQ27333104-41CCCD3D-F8D2-495A-924B-7482D0F6577FQ27335008-FC873901-DB0B-446A-A4F4-3F366F19AFECQ27490976-C9D094C9-DB8C-4FD1-9944-5CD632BD3F03Q30235512-9F403353-37C6-42DE-83F6-FF50DBBD3F6EQ30240191-63392BD8-5E75-415A-854C-63675F6BD550Q30376550-964C578A-7CB0-40A8-80C3-A7811B023214Q30384231-1C8D93B1-F4AD-4275-911C-4D46EEF10AF5Q30388754-04B9A367-DFD2-4BD6-BAEF-503CA13F126DQ30398956-3F738888-4B36-4302-BA40-1B46CE6F71D9Q30938741-980CE63C-CCD3-4A5B-A58F-8D2B5D9D6665Q33684369-0B1A7BD3-45F2-46D1-8D6B-0123CB52AF0EQ33916134-30616FE5-B763-49CD-BD33-38789094A1FAQ34046030-F2223414-1255-4975-AEE4-39FFE393946CQ34264257-A96A8B97-7320-43CF-A0DD-948A3A749BF6Q34394530-B045719F-08CC-4AFE-BF11-557E325AE395Q34630576-CBE01583-9584-42CB-B1BB-1120EBAC145CQ34697416-A079052A-CC44-41F0-B1A7-DC6D253ECA32Q34703785-4DB36AF4-DB9D-4055-A3BC-4783425D3712Q34901977-301F970D-E624-4826-890F-44B0F6C51EBFQ34992691-59568F1A-7713-4E37-AAC5-22BF0C07BC79Q35031851-B1CAB765-8EB4-40B2-ACFC-B6CC88601455Q35076889-75AD8BB3-F6E3-4BE4-BEB7-3109E1FFF894Q35109218-45C42E55-46B1-4D12-95D1-228AC7A66E87Q35140421-F496C3D7-5C71-47B4-B3DE-1E3C10B83772Q35142715-EB61B6AD-6363-4521-AF32-DD5A529942F1Q35192818-B003AB05-3973-47C3-B327-AE9A5E7E25ABQ35240173-E20F86E2-36CF-4E0D-8EC6-AFE5B6BB7E60
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Chimeric alphavirus vaccine candidates for chikungunya
@ast
Chimeric alphavirus vaccine candidates for chikungunya
@en
Chimeric alphavirus vaccine candidates for chikungunya
@nl
type
label
Chimeric alphavirus vaccine candidates for chikungunya
@ast
Chimeric alphavirus vaccine candidates for chikungunya
@en
Chimeric alphavirus vaccine candidates for chikungunya
@nl
prefLabel
Chimeric alphavirus vaccine candidates for chikungunya
@ast
Chimeric alphavirus vaccine candidates for chikungunya
@en
Chimeric alphavirus vaccine candidates for chikungunya
@nl
P2093
P2860
P50
P3181
P1433
P1476
Chimeric alphavirus vaccine candidates for chikungunya
@en
P2093
A Paige Adams
Eugenia Volkova
Naomi Forrester
Shu-Yuan Xiao
P2860
P304
P3181
P356
10.1016/J.VACCINE.2008.07.054
P407
P5008
P577
2008-09-15T00:00:00Z